The Insiders Extract Volume 187 - The Insiders Perspective on the Cannabis Market.

Insiders Extract (previously Cannabis Digest) is an expertly curated newsletter that delivers the most impactful articles, insights, and ideas to over 12,000 subscribers. If you like what you see, Subscribe to my direct feed.

This Month's Top Insights

1) Prescriber Insights into the use of cannabis in Aged Care

2) Insights from the Latest National Canada Cannabis Survey

3) U.S. Cannabis Retail Sales Soar to Record $32 Billion in June 2024

Highlights

Has the U.K. reached a cannabis tipping point?

The tipping point? UK cannabis clinics urged to clean up ‘concerning’ prescribing practices. The prescribing concerns in the U.K. echo the Australian market, leading to major backlashes, i.e., the recent TGA blanket crackdowns.

READ MORE

Germanys cannabis market charges ahead with growth on the rise!

Germany’s medical cannabis market morphs with increased imports, patient demand increases, and Ministerial pressure (akin to Australia) amidst country changes removing cannabis from ‘narcotic’ substance.

READ MORE & MORE

Insights

U.S. Cannabis Retail Sales Soar to Record $32 Billion in June 2024 - a case for Adult Use Cannabis.

Prescriber Insights into the use of Cannabis in Aged Care. Written by Dr Jagdeesh Singh Dhaliwal

A wasteful industry, why companies should consider reused materials for their packaging VS outdated plastic packaging.

Insights from the Latest National Canada Cannabis Survey: Market Growth, Consumer Product Preferences, and Purchase Rationals.

Major News

Grounding of British Airways flight sparks calls for more medical cannabis education for security and law enforcement agencies.

DEA delays cannabis rescheduling decision until after the election, with the stock marketing taking a significant hit as a result.

Moroccan King Mohammed VI pardons over 4,800 cannabis growers, a testament reflecting Morocco's evolving cannabis policy in recent years.

The second major disappointment for Jazz as cannabidiol therapy flunks in Japanese Phase III trial – in 2022, Sativex failed a Phase III study.

Ukraine legalises medical cannabis – Insomnia and PTSD not included on the official list of conditions, instead an ‘other diseases’ category has been established.

After years of delay, the Mexican Cannabis Market may finally receive the regulatory changes needed to finally start functioning. This comes after the newly elected presidents pledge to support cannabis access across the country. #import #export opportunities!

Case Studies & Research

USC study finds cannabis can help manage withdrawal symptoms, as well as cravings and anxiety after withdrawal.

Medical Cannabis as a Debated Alternative in Pain Management and Opioid Reduction, what do the research say?

Cannabinoids and monoaminergic system: implications for learning and memory.

Australian professor supports John Lennon’s bizarre cannabis-contact lens claim that his contact lenses would not fall out if he was ‘stoned’ on cannabis.

The Motivations of a Wake-and-Bake Cannabis Lifestyle Early morning cannabis use, often to avert anxiety, is increasing—and risky.

Low does CBD does not improve physical and mental health measures in healthy individuals – whilst note specified this study is likely using CBD isolate VS Full Spectrum.

This Months Industry Quote

“The path to wisdom is paved with humility.” — Tim Fargo

If you like what you see, Subscribe to my direct feed.

This is an industry newsletter for the purpose of providing scientific and regulatory updates in respect of medical cannabis industries globally. Nothing in this newsletter is intended to promote the use or supply of medical cannabis to members of the public.